Showing results (271-280 of 307) with videos related to
Sort By:
Pageof 31
The Bone & Joint Journal|November 6, 2014
Classification of failure of limb salvage after reconstructive surgery for bone tumours : a modified system Including biological and expandable reconstructionsE R Henderson, M I O'Connor, P Ruggieri, et al.Journal of the American College of Cardiology|September 14, 1999
Pretreatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversionA De Simone, G Stabile, D F Vitale, et al.Neurology|June 27, 2001
Temporal lobe epilepsy due to hippocampal sclerosis in pediatric candidates for epilepsy surgeryA Mohamed, E Wyllie, P Ruggieri, et al.Cancer|August 3, 1999
Italian Cooperative Study for the treatment of children and young adults with localized Ewing sarcoma of bone: a preliminary report of 6 years of experienceP Rosito, A F Mancini, R Rondelli, et al.Circulation|December 1, 1996
Myocardial ultrasonic tissue characterization in pediatric and adult patients with hypertrophic cardiomyopathyD F Vitale, R O Bonow, R Calabrò, et al.The American Journal of Cardiology|June 1, 1988
The effect of coronary artery bypass grafting on left ventricular systolic function at rest: evidence for preoperative subclinical myocardial ischemiaV Dilsizian, R O Bonow, R O Cannon, et al.Journal of the American College of Cardiology|May 10, 2001
Response to flecainide infusion predicts long-term success of hybrid pharmacologic and ablation therapy in patients with atrial fibrillationG Stabile, A De Simone, P Turco, et al.International Journal of Epidemiology|April 6, 2000
Antibodies to human herpes virus type 8 (HHV8) in general population and in individuals at risk for sexually transmitted diseases in Western SicilyA M Perna, F Bonura, F Vitale, et al.Clinical Orthopaedics and Related Research|August 16, 2000
Analysis of 12q13-15 genes in parosteal osteosarcomaG Gamberi, P Ragazzini, M S Benassi, et al.Tumori|April 25, 2000
Nonmetastatic osteosarcoma of the extremity: results of a neoadjuvant chemotherapy protocol (IOR/OS-3) with high-dose methotrexate, intraarterial or intravenous cisplatin, doxorubicin, and salvage chemotherapy based on histologic tumor responseS Ferrari, M Mercuri, P Picci, et al.Pageof 31